We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

31 hedge funds and large institutions have $16.6M invested in Apollo Endosurgery, Inc. in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

0% more funds holding

Funds holding: 3131 (0)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

31% less capital invested

Capital invested by funds: $24M → $16.6M (-$7.38M)

Holders
31
Holders Change
Holders Change %
0%
% of All Funds
0.68%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
3
Increased
9
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
-$212K -74,401 Closed
Citadel Advisors
27
Citadel Advisors
Florida
-$31K -10,758 Closed
RWA
28
Ropes Wealth Advisors
Massachusetts
-$2K -600 Closed
Wells Fargo
29
Wells Fargo
California
+$210 +80 +2,667%

APEN Hedge Fund Activity: Q1 2020 in Review

31 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2020, worth a combined $16.6M — down 31% from $24M a quarter earlier.

Fund positioning in APEN was balanced in Q1 2020: 3 funds opened new positions, 3 closed out, 9 added to existing stakes and 2 trimmed.

The largest buyer was Prosight Management, adding an estimated $467K. The largest seller was Russell Investments Group, exiting entirely with an estimated $212K sold.

  • 31 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $16.6M of Apollo Endosurgery, Inc. stock for Q1 2020, down 31% quarter-over-quarter.
  • 3 funds opened new Apollo Endosurgery, Inc. positions in Q1 2020 and 3 closed out, a net change of 0 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q1 2020 was Prosight Management, an estimated $467K added.
  • The largest Apollo Endosurgery, Inc. seller in Q1 2020 was Russell Investments Group, an estimated $212K sold.

Based on aggregated 13F filings for Q1 2020.